Total neoadjuvant treatment for mri-stratified high-risk rectal cancer: a single-center, single-arm, prospective phase ii trial (pkuch-r02)

HIGHLIGHTS

• who: The inclusion criteria were and colleagues from the University Cancer Hospital (Beijing, China) and performed in accordance with Helsinki Declaration (G2015-0816)Written have published the Article: Total neoadjuvant treatment for MRI-stratified high-risk rectal cancer: a single-center, single-arm, prospective Phase II trial (PKUCH-R02), in the Journal: (JOURNAL) of 29/06/2022
• what: All the patients enrolled in this study had at least one high risk factor. In this prospective Phase II study, the authors focused on rectal cancer patients with a high risk of distant metastasis.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.